ABBVIE INC

ABBV New York Stock Exchange
249,46 $
Last updated: 2026-08-16

AbbVie is a global biopharmaceutical company focused on discovering and delivering innovative medicines for serious health conditions.

Dividend (2025)
6,56 $
Yield (2025)
2,63 %
Market Cap
440.83B $
P/E Ratio
70,56

Dividend History

Year Dividend Yield
2025 6,56 $
2024 6,20 $
2023 5,92 $
2022 5,64 $
2021 5,20 $
Dividend growth rate: 5.98% (4-year CAGR)

Quick Analysis

Dividend Score 6/10

Key Insights

  • Consistent dividend history
Continue after this ad

News

Stocks Aug 10
ABBVIE INC — New York Stock Exchange (NYSE)

AbbVie joins our list of companies with regular, stable or growing dividends. The U.S. pharmaceutical group is supported by the growth of Skyrizi and Rinvoq, and its stock trades under the ticker ABBV.

Track This Stock

Get alerts and detailed analysis

Top Dividend Stocks

Finance

M6 METROPOLE TELE

MMT

ITOCHU CORPORATION

8001

FDJ UNITED

FDJU

* Financial information and dividend data are provided for informational purposes only and do not constitute investment advice.